22:14:57 EST Sun 28 Nov 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Opsens Inc
Symbol OPS
Shares Issued 106,815,539
Close 2021-07-07 C$ 2.20
Recent Sedar Documents

Opsens to release Q3 2021 results July 13

2021-07-07 12:17 ET - News Release

An anonymous director reports

OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, JULY 13, 2021

Opsens Inc. will report its financial results for its third quarter of fiscal year 2021, ended May 31, 2021, on Tuesday, July 13, 2021, before the open of the market. The company has scheduled a conference call the same day, at 11 a.m. ET, to review the results.

Interested parties can access the conference call by dialling 833-756-0865 or 412-317-5754 or can listen via a live Internet webcast, available in the investors section of the company's website.

A teleconference replay of the call will be available for three days at 877-344-7529 or 412-317-0088, confirmation pound sign followed by 10158097. A webcast replay will be available in the investors section of the company's website.

About Opsens Inc.

Opsens focuses mainly on interventional cardiology. The company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fibre optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesion access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, the European Union, Japan and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fiber optic sensing solutions for critical applications.

© 2021 Canjex Publishing Ltd. All rights reserved.